{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:52:52Z","timestamp":1792479172350,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.arbres.2022.12.015","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T11:14:02Z","timestamp":1673090042000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?"],"prefix":"10.1016","volume":"59","author":[{"given":"Eileen M.","family":"Dunne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catia","family":"Cilloniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"von Mollendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lewnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay R.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary P.E.","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Jodar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Theilacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2022.12.015_bib0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-2005-925523","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and clinical features","volume":"26","author":"\u00d6rtqvist","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.12.015_bib0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arbres.2022.12.015_bib0215","unstructured":"Apexxnar. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/apexxnar [accessed 11.04.22]."},{"key":"10.1016\/j.arbres.2022.12.015_bib0220","series-title":"Global market study: pneumococcal conjugate (PCV) and polysaccharide (PPV) vaccines \u2013 2020","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.arbres.2022.12.015_bib0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3122\/jabfm.2018.01.170216","article-title":"Primary care physicians\u2019 struggle with current adult pneumococcal vaccine recommendations","volume":"31","author":"Hurley","year":"2018","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.arbres.2022.12.015_bib0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/pathogens9040259","article-title":"A systematic review of studies published between 2016 and 2019 on the effectiveness and efficacy of pneumococcal vaccination on pneumonia and invasive pneumococcal disease in an elderly population","volume":"9","author":"Berild","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.arbres.2022.12.015_bib0235","article-title":"Systematic review and meta-analysis of the efficacy and effectiveness of pneumococcal vaccines in adults","author":"Loo","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.arbres.2022.12.015_bib0240","series-title":"Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.arbres.2022.12.015_bib0245","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.arbres.2022.12.015_bib0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14760584.2021.1889376","article-title":"The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia","volume":"20","author":"Gessner","year":"2021","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.arbres.2022.12.015_bib0255","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/cid\/ciy312","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older us adults: a test-negative design","volume":"67","author":"McLaughlin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0260","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/microorganisms10030560","article-title":"23-Valent pneumococcal polysaccharide vaccination does not prevent community-acquired pneumonia hospitalizations due to vaccine-type Streptococcus pneumoniae","volume":"10","author":"Chandler","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.arbres.2022.12.015_bib0265","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/infdis\/jiab474","article-title":"Effectiveness of pneumococcal vaccination against pneumococcal pneumonia hospitalization in older adults: a prospective, test-negative study","volume":"225","author":"Heo","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0270","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/ecco-jcc\/jjab017","article-title":"Effectiveness of conjugate and polysaccharide pneumococcal vaccines for prevention of severe pneumococcal disease among inflammatory bowel disease patients","volume":"15","author":"Love","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0275","series-title":"Epidemiologisches Bulletin 07\/2014. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung %J Epidemiologisches Bulletin 2014","author":"Koch-Institut","year":"2014"},{"key":"10.1016\/j.arbres.2022.12.015_bib0280","series-title":"Epidemiologisches Bulletin 07\/2012. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung %J Epidemiologisches Bulletin 2012","author":"Koch-Institut","year":"2012"},{"key":"10.1016\/j.arbres.2022.12.015_bib0285","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cmi.2017.08.010","article-title":"Impact of pneumococcal polysaccharide vaccine on incidence and mortality after pneumonia in adults aged \u226560 years-a population-based retrospective cohort study","volume":"24","author":"Kolditz","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.arbres.2022.12.015_bib0290","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/cid\/ciy993","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of all-cause pneumonia in adults aged \u226560 years: a population-based, retrospective cohort study","volume":"68","author":"Kolditz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0295","first-page":"ciab1051","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults","author":"Lewnard","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0300","doi-asserted-by":"crossref","first-page":"e221111","DOI":"10.1001\/jamanetworkopen.2022.1111","article-title":"Incidence and estimated vaccine effectiveness against hospitalizations for all-cause pneumonia among older US adults who were vaccinated and not vaccinated with 13-valent pneumococcal conjugate vaccine","volume":"5","author":"Hsiao","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arbres.2022.12.015_bib0305","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/infdis\/jiab128","article-title":"Prevention of Coronavirus Disease 2019 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the respiratory tract","volume":"225","author":"Lewnard","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0310","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cid\/cis359","article-title":"Pneumococcal conjugate vaccine for adults: a new paradigm","volume":"55","author":"Paradiso","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0315","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.rmed.2011.07.008","article-title":"Pneumococcal vaccination in adults: does it really work?","volume":"105","author":"Pitsiou","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2022.12.015_bib0320","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.201503-0542OC","article-title":"First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial","volume":"192","author":"Collins","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.12.015_bib0325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/mi.2016.71","article-title":"Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage","volume":"10","author":"Mitsi","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.arbres.2022.12.015_bib0330","doi-asserted-by":"crossref","first-page":"eabm4065","DOI":"10.1126\/scitranslmed.abm4065","article-title":"Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses","volume":"14","author":"Davies","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.arbres.2022.12.015_bib0335","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"2013","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2022.12.015_bib0340","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2022.12.015_bib0345","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(97)07358-3","article-title":"Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people","volume":"351","author":"Ortqvist","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2022.12.015_bib0350","doi-asserted-by":"crossref","first-page":"e0169368","DOI":"10.1371\/journal.pone.0169368","article-title":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis","volume":"12","author":"Falkenhorst","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2022.12.015_bib0355","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1016\/j.vaccine.2019.07.040","article-title":"Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial","volume":"37","author":"Gessner","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.arbres.2022.12.015_bib0360","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1016\/j.vaccine.2019.10.013","article-title":"Pneumonia endpoints must be standardized for adult pneumococcal vaccine trials","volume":"38","author":"Suzuki","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.arbres.2022.12.015_bib0365","doi-asserted-by":"crossref","first-page":"c1004","DOI":"10.1136\/bmj.c1004","article-title":"Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial","volume":"340","author":"Maruyama","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.arbres.2022.12.015_bib0370","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cid\/cix1066","article-title":"Pneumococcal community-acquired pneumonia detected by serotype-specific urinary antigen detection assays","volume":"66","author":"Wunderink","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0375","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"McCullers","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.arbres.2022.12.015_bib0380","first-page":"jiac098","article-title":"Effectiveness of pneumococcal conjugate vaccination against virus-associated lower respiratory tract infection among adults: a case\u2013control study","author":"Lewnard","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0385","first-page":"2060","article-title":"Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies","volume":"45","author":"Lipsitch","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.arbres.2022.12.015_bib0390","doi-asserted-by":"crossref","first-page":"e0220453","DOI":"10.1371\/journal.pone.0220453","article-title":"Limited indirect effects of an infant pneumococcal vaccination program in an aging population","volume":"14","author":"van der Linden","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2022.12.015_bib0395","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1473-3099(17)30051-8","article-title":"Time to follow up when comparing studies of pneumococcal vaccines","volume":"17","author":"Pletz","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.arbres.2022.12.015_bib0400","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289623000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289623000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:42:17Z","timestamp":1759531337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289623000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0300289623000030"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2022.12.015","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2022.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}